Modern Diagnostic Ipo
Modern Diagnostic IPO Review & Key Points
Review: Neutral
Rating: 2
IPO Lead Managers aka Merchant Bankers
Beeline Capital Advisors Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 3,200 | ₹2,88,000 |
| Retail Maximum | 2 | 3,200 | ₹2,88,000 |
| S-HNI Minimum | 3 | 4,800 | ₹4,32,000 |
| S-HNI Maximum | 6 | 9,600 | ₹8,64,000 |
| B-HNI Minimum | 7 | 11,200 | ₹10,08,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 11,61,600 Shares | 28.34% |
| QIB (Ex. Anchor) | 7,82,400 Shares | 19.09% |
| NII Shares Offered | 5,85,600 Shares | 14.29% |
| Retail Shares Offered | 13,63,200 Shares | 33.26% |
| Anchor Bidding Date | December 30, 2025 |
| Anchor Investors List | |
| Shares Offered | 11,61,600 Shares |
| Anchor Size | 10.45 Cr. |
| lock-in period end date 50% shares (30 Days) | February 4, 2026 |
| lock-in period end date 50% shares (90 Days) | April 5, 2026 |
| IPO Open Date: | December 31, 2025 |
| IPO Close Date: | January 2, 2026 |
| Basis of Allotment: | January 5, 2026 |
| Refunds: | January 6, 2026 |
| Credit to Demat Account: | January 6, 2026 |
| IPO Listing Date: | January 7, 2026 |
| IPO Bidding Cut-off Time: | January 2, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,10,00,000 | 99.99% |
| Promoter Holding Post Issue | 1,50,99,200 | 72.85% |
| Purpose | Crores |
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | ₹20.69 |
| Funding Working Capital Requirement | ₹11.60 |
| Repayment of certain outstanding borrowings availed by the Company | ₹4.50 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹56.61 | ₹62.55 | ₹5.73 | ₹36.54 |
| 2024 | ₹68.67 | ₹61.81 | ₹5.79 | ₹49.49 |
| 2025 | ₹78.80 | ₹66.08 | ₹8.97 | ₹64.57 |
| June 2025 | ₹22.67 | ₹18.40 | ₹3.00 | ₹77.86 |
| KPI | Values |
| ROE: | 55.21% |
| ROCE: | 36.18% |
| EBITDA Margin: | 23.04% |
| PAT Margin: | 11.51% |
| Debt to equity ratio: | 1.07 |
| Earning Per Share (EPS): | ₹8.15 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 43.27% |
| Net Asset Value (NAV): | ₹18.84 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Vijaya Diagnostic Centre Limited | 13.92 | 72.36 | 18.07% | 77.42 | – Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date | December 31, 2025 |
| IPO Close Date | January 2, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹85 to ₹90 Per Share |
| Issue Size | Approx ₹37 Crores |
| Fresh Issue | Approx ₹37 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |